Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177057 · ClinicalTrials.gov registry record · NA
SMART Project in Preventing Skin Cancer
A NA study of Skin Carcinoma, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT03177057 is a NA study of Skin Carcinoma that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 114 participants, below the 261-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03177057, a NA study of Skin Carcinoma, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best prevention plan and decrease national melanoma incidence and mortality.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Health Telemonitoring
- BEHAVIORAL Compliance Monitoring
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2013-04-23 |
| Est. Completion | 2014-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03177057
The ClinicalTrials.gov registry entry for NCT03177057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (56% lower). The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03177057 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03177057 about?
NCT03177057 is a clinical study titled "SMART Project in Preventing Skin Cancer". This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best preven...
What is the current status of trial NCT03177057?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2013-04-23. Estimated completion is 2014-12-31.
What conditions does trial NCT03177057 study?
This clinical trial studies the following conditions: Skin Carcinoma.
What interventions are being tested in trial NCT03177057?
The interventions under investigation include: Questionnaire Administration (OTHER), Health Telemonitoring (OTHER), Compliance Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03177057?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03177057 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
ACTIVE NOT RECRUITING · NA
-
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
ACTIVE NOT RECRUITING · NA
-
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
COMPLETED · NA
-
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.